COLUMBUS, Ohio, July 23 (Nationwide Times) — A specially made tomato-soy drink may have nudged down some inflammation signals in adults with obesity, according to a study published in Molecular Nutrition & Food Research and indexed in PubMed. For everyday readers, the main point is modest: the result is promising, but it comes from a very small trial and is not a reason to treat the drink as a proven health fix.
What the researchers tested
Ohio State researchers studied 12 adults with obesity. Each person drank two 6-ounce servings a day for four weeks of either a tomato-soy beverage or a low-carotenoid tomato juice used as the comparison drink. The study used a crossover design, which means the same participants tried both drinks at different times, with a washout period in between.
The test drink was not ordinary tomato juice. It was made from tomatoes bred to contain high levels of lycopene and was fortified with soy isoflavones, two plant compounds that have been studied for possible health effects.
What changed in the body
After the tomato-soy drink, the study found significant drops in three cytokines, which are immune-system messenger proteins linked to inflammation: IL-5, IL-12p70 and GM-CSF. TNF-alpha also moved downward, but it did not meet the usual cutoff for statistical significance.
The researchers also reported a 2.48-fold increase in plasma lycopene. In addition, both drinks produced some shared changes in urine molecules, which the study said suggests the tomato component may have effects beyond lycopene alone.
What this does and does not mean
The study does not show that tomato juice is a treatment for inflammation or obesity. It shows short-term changes in lab markers in 12 adults. That makes it an early step, not a final answer.
Larger studies would be needed to know whether the drink changes outcomes that matter in daily life, such as long-term health, symptoms, or disease risk. The available results also do not say how the drink would work in people who are not part of the study group.
Why scientists are paying attention
This is not the first tomato-juice study to look at inflammation. A separate 2013 randomized study indexed in PubMed found that tomato juice lowered some inflammatory markers in overweight or obese female students at Tehran University of Medical Sciences. In that trial, IL-8 and TNF-alpha fell in the intervention group, and IL-6 decreased in obese participants.
Taken together, the studies suggest tomatoes may influence inflammation biology. But the evidence is still preliminary, and the Ohio State study was too small to support broad dietary recommendations on its own.
